Skip to content
Catalyst

PapersPMID:22246619

Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women.

Cancer prevention research (Philadelphia, Pa.)2012The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, moderate evidenceno difference foundBody mass index
  2. Finding, limited evidenceno difference foundGlycated haemoglobin (HbA1c)
Study, every finding
RCT · 2 months
Dose studied, every finding
four capsules daily, 400 mg or 800 mg EGCG as PPE per day

No finding here moved its endpoint.

  • “There were no significant differences in changes in body weight or BMI after 2 months of intervention between the placebo and PPE groups.”
    Population
    Healthy postmenopausal women aged 45 or older (103 analysed: 32 placebo, 37 on 400 mg EGCG as PPE, 34 on 800 mg EGCG as PPE); PPE dose groups reported together
  • “Levels of HbA1c decreased slightly in both PPE groups; the difference in change did not differ significantly between the placebo group and the PPE groups (P=0.26).”
    Population
    Healthy postmenopausal women aged 45 or older (103 analysed: 32 placebo, 37 on 400 mg EGCG as PPE, 34 on 800 mg EGCG as PPE); PPE dose groups combined for the between-arm test

Study record

Design
randomised controlled trial
Species
human
Population
Healthy postmenopausal women (45 years or older, non-current hormone therapy users); Polyphenon E (green tea catechin extract, EGCG main component) 400 mg or 800 mg EGCG daily vs placebo for 2 months
Participants
103
Comparator
placebo
Duration
61 days
Endpoints measured
39
Declined
the intervention held more than the compound